Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Director | April 29, 2022 | May 03, 2022 |
| CATERPILLAR INCCAT · Entity 2808 | Director | March 01, 2021 | March 03, 2021 |
| GENERAL DYNAMICS CORPGD · Entity 2916 | Director | March 08, 2021 | March 10, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date April 29, 2022 · Filed May 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 98,598 |
Reported balance
After 2022-04-29 transaction · row 1
1 source rowRow 1 · 2022-04-29 · Grant · Acquired 1,602 · Balance 98,598 F1: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $115.46 · Expires 2032-04-28 | Direct | 8,106 |
Reported balance
After 2022-04-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-04-29 · Grant · Acquired 8,106 · Balance 8,106 F2: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
CATERPILLAR INC
Report date March 01, 2021 · Filed March 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,199 |
Reported balance
After 2021-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-03-01 · Grant · Acquired 683 · Balance 54,199 F1: Includes adjustments for dividends accrued. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes adjustments for dividends accrued.
GENERAL DYNAMICS CORP
Report date March 08, 2021 · Filed March 10, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,266 |
Reported balance
After 2021-03-08 transaction · row 1
1 source rowRow 1 · 2021-03-08 · Tax withholding · Disposed 74 · Balance 36,266 F1: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 29, 2022 Filed May 3, 2022 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 8,106 | $0.00 Strike: $115.46 | $0.00 |
DisclosureSEC source: 0001415889-22-004552 · form4-05032022_030503.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,106 Underlying: Common Shares · 8,106 shares Expires 2032-04-28 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 29, 2022 Filed May 3, 2022 22:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004552 · form4-05032022_030503.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,598 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| October 26, 2021 Filed Oct 27, 2021 22:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 15,752 | $0.00 Strike: $59.42 | $0.00 |
DisclosureSEC source: 0001415889-21-004997 · form4-10272021_031001.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 15,752 shares Expires 2028-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 26, 2021 Filed Oct 27, 2021 22:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 15,752 | $59.42 | $935,983.84 |
DisclosureSEC source: 0001415889-21-004997 · form4-10272021_031001.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 23:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 7,586 | $0.00 Strike: $123.38 | $0.00 |
DisclosureSEC source: 0001415889-21-002160 · form4-04272021_040422.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,586 Underlying: Common Shares · 7,586 shares Expires 2031-04-22 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 23:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002160 · form4-04272021_040422.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,244 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 20:02 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 74 | $172.96 | $12,799.04 |
DisclosureSEC source: 0001209191-21-019416 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,266 F1 · kind: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 14:10 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 2,770 | $0.00 Strike: $168.56 | $0.00 |
DisclosureSEC source: 0001209191-21-018069 · doc4.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,770 Underlying: Common Stock · 2,770 shares Expires 2031-03-02 F2 · derivative.exercise_date: Fifty percent become exercisable on 03/03/2023 and the remaining fifty percent become exercisable on 03/03/2024. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 14:10 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018069 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,340 F1 · kind: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 19:49 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantCommon Stock | 683 | $0.00 | $0.00 |
DisclosureSEC source: 0000018230-21-000099 · wf-form4_161480097148206.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,199 F1 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 22:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 21,448 | $0.00 Strike: $43.64 | $0.00 |
DisclosureSEC source: 0001179110-20-011416 · edgar.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 21,448 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 22:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 21,448 | $43.64 | $935,990.72 |
DisclosureSEC source: 0001179110-20-011416 · edgar.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 22:09 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionStock Options · Derivative | 4,400 | $0.00 Strike: $112.40 | $0.00 |
DisclosureSEC source: 0001209191-20-057682 · doc4.xml · derivative · entry 3 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,400 shares Expires 2021-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fifty percent became exercisable on 03/05/2015 and the remaining fifty percent became exercisable on 03/05/2016. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 22:09 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | SaleCommon Stock | 3,594 | $147.14 | $528,824.75 |
DisclosureSEC source: 0001209191-20-057682 · doc4.xml · nonDerivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,865 F1 · price: Sale prices ranged from $147.09 to $147.16. Reporting Person will provide, upon request by the Commission staff, General Dynamics, or a General Dynamics shareholder, full information regarding the number of shares sold at each separate sales price. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 22:09 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionCommon Stock | 4,400 | $112.40 | $494,560.00 |
DisclosureSEC source: 0001209191-20-057682 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 11, 2020 20:24 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GiftCommon Stock | 1,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-046115 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,059 Read SEC document |
| August 10, 2020 Filed Jan 25, 2021 23:38 UTC | CATERPILLAR INC CAT · Entity 2808 | GiftCommon Stock | 1,471 | $0.00 | $0.00 |
DisclosureSEC source: 0000018230-21-000016 · wf-form4_161161790955930.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,510 F1 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 21:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 9,991 | $0.00 Strike: $93.68 | $0.00 |
DisclosureSEC source: 0001179110-20-005187 · edgar.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,991 Underlying: Common shares · 9,991 shares Expires 2030-04-23 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 21:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-005187 · edgar.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,297 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 19:35 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 3,210 | $0.00 Strike: $165.47 | $0.00 |
DisclosureSEC source: 0001209191-20-016508 · doc4.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,210 Underlying: Common Stock · 3,210 shares Expires 2030-03-03 F2 · derivative.exercise_date: Fifty percent become exercisable on 03/04/2022 and the remaining fifty percent become exercisable on 03/04/2023. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 19:35 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016508 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,369 F1 · kind: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 19:32 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 86 | $161.42 | $13,882.12 |
DisclosureSEC source: 0001209191-20-014987 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,884 F1 · kind: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 23:35 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantCommon Stock | 1,176 | $0.00 | $0.00 |
DisclosureSEC source: 0000018230-20-000098 · wf-form4_158327848341180.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,955 F1 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 20:44 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 115 | $177.98 | $20,467.70 |
DisclosureSEC source: 0001209191-20-001686 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,970 F1 · kind: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 17:59 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionStock Options · Derivative | 6,900 | $0.00 Strike: $67.70 | $0.00 |
DisclosureSEC source: 0001209191-19-044752 · doc4.xml · derivative · entry 3 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,900 shares Expires 2020-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fifty percent became exercisable on 03/06/2014 and the remaining fifty percent became exercisable on 03/06/2015. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 17:59 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | SaleCommon Stock | 1,500 | $182.56 | $273,840.00 |
DisclosureSEC source: 0001209191-19-044752 · doc4.xml · nonDerivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,085 Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 17:59 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionCommon Stock | 6,900 | $67.70 | $467,130.00 |
DisclosureSEC source: 0001209191-19-044752 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 21:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 11,990 | $0.00 Strike: $78.06 | $0.00 |
DisclosureSEC source: 0001179110-19-005311 · edgar.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,990 Underlying: Common shares · 11,990 shares Expires 2029-04-25 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 21:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005311 · edgar.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,323 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 21:50 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 2,590 | $0.00 Strike: $167.61 | $0.00 |
DisclosureSEC source: 0001209191-19-017799 · doc4.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,590 Underlying: Common Stock · 2,590 shares Expires 2029-03-05 F2 · derivative.exercise_date: Fifty percent become exercisable on 03/06/2021 and the remaining fifty percent become exercisable on 03/06/2022. Read SEC document |
| March 06, 2019 Filed Mar 7, 2019 21:50 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 445 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017799 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,685 F1 · shares: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:02 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantCommon Stock | 1,084 | $0.00 | $0.00 |
DisclosureSEC source: 0000018230-19-000104 · wf-form4_155191333387437.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,746 F1 · balance_after: Includes adjustments for dividends accrued. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 17:27 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 115 | $155.64 | $17,898.60 |
DisclosureSEC source: 0001209191-19-001722 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,240 F1 · kind: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares. Read SEC document |
| April 27, 2018 Filed May 1, 2018 23:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 15,752 | $0.00 Strike: $59.42 | $0.00 |
DisclosureSEC source: 0001179110-18-006028 · edgar.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,752 Underlying: Common shares · 15,752 shares Expires 2028-04-26 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 27, 2018 Filed May 1, 2018 23:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006028 · edgar.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,082 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 19:50 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionStock Options · Derivative | 4,580 | $0.00 Strike: $71.01 | $0.00 |
DisclosureSEC source: 0001209191-18-020102 · doc4.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,580 shares Expires 2018-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fifty percent became exercisable on 03/07/2013 and the remaining fifty percent became exercisable on 03/07/2014. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 19:50 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionCommon Stock | 4,580 | $71.01 | $325,225.80 |
DisclosureSEC source: 0001209191-18-020102 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 21:41 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 1,990 | $0.00 Strike: $223.93 | $0.00 |
DisclosureSEC source: 0001209191-18-018071 · doc4.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,990 Underlying: Coimmon Stock · 1,990 shares Expires 2028-03-06 F2 · derivative.exercise_date: Fifty percent become exercisable on 03/07/2020 and the remaining fifty percent become exercisable on 03/07/2021. Read SEC document |
| March 07, 2018 Filed Mar 8, 2018 21:41 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-018071 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,775 F1 · shares: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:05 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantCommon Stock | 993 | $0.00 | $0.00 |
DisclosureSEC source: 0000018230-18-000092 · wf-form4_152046747937507.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,638 Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 20:10 UTC | CATERPILLAR INC CAT · Entity 2808 | SaleCommon Stock | 5,000 | $113.67 | $568,350.00 |
DisclosureSEC source: 0000018230-17-000243 · edgar.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,645 F1 · price: The sale price reported in Column 4 is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $113.66 to $113.69, inclusive. The reporting person undertakes to provide Caterpillar Inc., any security holder of Caterpillar Inc., or the staff of the Securities and Exchange Commission, upon request, full information. F2 · balance_after: Reflects adjustments for clerical error to total shares of Common Stock of the Issuer previously reported as beneficially owned by Mr. Osborn. Read SEC document |
| April 28, 2017 Filed May 2, 2017 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 21,448 | $0.00 Strike: $43.64 | $0.00 |
DisclosureSEC source: 0001179110-17-006409 · edgar.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,448 Underlying: Common shares · 21,448 shares Expires 2027-04-27 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 28, 2017 Filed May 2, 2017 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006409 · edgar.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,137 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 23:15 UTC | CATERPILLAR INC CAT · Entity 2808 | GrantCommon Stock | 1,307 | $0.00 | $0.00 |
DisclosureSEC source: 0000018230-17-000082 · edgar.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,251 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 19:35 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 2,270 | $0.00 Strike: $191.71 | $0.00 |
DisclosureSEC source: 0001209191-17-017236 · doc4.xml · derivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,270 Underlying: Common Stock · 2,270 shares Expires 2027-02-28 F2 · derivative.exercise_date: Fifty percent become exercisable on 03/01/2019 and the remaining fifty percent become exercisable on 03/01/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 19:35 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock, $1.00 par value | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017236 · doc4.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,440 F1 · shares: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 1,015 | $38.41 Strike: $0.00 | $38,986.15 |
DisclosureSEC source: 0001179110-17-000266 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,963 Underlying: Common shares · 1,015 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 21:09 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 922 | $42.29 Strike: $0.00 | $38,991.38 |
DisclosureSEC source: 0001179110-16-030313 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,780 Underlying: Common shares · 922 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2016 Filed Jul 5, 2016 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 953 | $39.31 Strike: $0.00 | $37,462.43 |
DisclosureSEC source: 0001179110-16-027358 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,715 Underlying: Common shares · 953 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 29, 2016 Filed May 3, 2016 21:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-023679 · edgar.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,700 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.